Complete Remission Obtained with Azacitidine in a Patient with Concomitant Therapy Related Myeloid Neoplasm and Pulmonary Mucormycosis
Mucormycosis is the third cause of invasive mycosis after candidiasis and aspergillosis in AML patients, representing a poor prognostic factor associated with a high rate of fatal outcome. We report a case of a patient with AML and a concomitant pulmonary mucormycosis at diagnosis, who obtained...
Saved in:
| Main Authors: | Saveria Capria, Federico De Angelis, Giuseppe Gentile, Silvia Maria Trisolini, Simonetta Brocchieri, Martina Canichella, Patrizia Chiusolo, Alessandra Micozzi, Robin Foà, Giovanna Meloni |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2013-07-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Subjects: | |
| Online Access: | http://www.mjhid.org/index.php/mjhid/article/view/477 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COMPLETE REMISSION IN A PATIENT WITH CONCOMITANT DIAGNOSIS OF ACUTE MYELOID LEUKEMIA AND PULMONARY MUCORMICOSIS
by: saveria capria, et al.
Published: (2014-08-01) -
AZACITIDINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA: AN EFFECTIVE AND MANAGEABLE APPROACH.
by: Pasquale Niscola
Published: (2014-02-01) -
Impact of the relative dose intensity on survival of patients with high‐risk myelodysplastic syndromes treated with Azacitidine
by: Kamel Laribi, et al.
Published: (2019-05-01) -
Osteoarticular mucormycosis of the distal femur in a post COVID-19 patient
by: Srinivas Kasha, et al.
Published: (2024-12-01) -
Combination therapy with venetoclax and azacitidine for the treatment of myelodysplastic syndromes with DDX41 mutations
by: Xin Wang, et al.
Published: (2024-12-01)